EUR-Lex Access to European Union law
This document is an excerpt from the EUR-Lex website
Document 02021R0620-20240218
Commission Implementing Regulation (EU) 2021/620 of 15 April 2021 laying down rules for the application of Regulation (EU) 2016/429 of the European Parliament and of the Council as regards the approval of the disease-free and non-vaccination status of certain Member States or zones or compartments thereof as regards certain listed diseases and the approval of eradication programmes for those listed diseases (Text with EEA relevance)Text with EEA relevance
Consolidated text: Commission Implementing Regulation (EU) 2021/620 of 15 April 2021 laying down rules for the application of Regulation (EU) 2016/429 of the European Parliament and of the Council as regards the approval of the disease-free and non-vaccination status of certain Member States or zones or compartments thereof as regards certain listed diseases and the approval of eradication programmes for those listed diseases (Text with EEA relevance)Text with EEA relevance
Commission Implementing Regulation (EU) 2021/620 of 15 April 2021 laying down rules for the application of Regulation (EU) 2016/429 of the European Parliament and of the Council as regards the approval of the disease-free and non-vaccination status of certain Member States or zones or compartments thereof as regards certain listed diseases and the approval of eradication programmes for those listed diseases (Text with EEA relevance)Text with EEA relevance
02021R0620 — EN — 18.02.2024 — 009.001
This text is meant purely as a documentation tool and has no legal effect. The Union's institutions do not assume any liability for its contents. The authentic versions of the relevant acts, including their preambles, are those published in the Official Journal of the European Union and available in EUR-Lex. Those official texts are directly accessible through the links embedded in this document
COMMISSION IMPLEMENTING REGULATION (EU) 2021/620 of 15 April 2021 laying down rules for the application of Regulation (EU) 2016/429 of the European Parliament and of the Council as regards the approval of the disease-free and non-vaccination status of certain Member States or zones or compartments thereof as regards certain listed diseases and the approval of eradication programmes for those listed diseases (OJ L 131 16.4.2021, p. 78) |
Amended by:
|
|
Official Journal |
||
No |
page |
date |
||
COMMISSION IMPLEMENTING REGULATION (EU) 2021/1008 of 21 June 2021 |
L 222 |
12 |
22.6.2021 |
|
COMMISSION IMPLEMENTING REGULATION (EU) 2021/1911 of 27 October 2021 |
L 389 |
2 |
4.11.2021 |
|
COMMISSION IMPLEMENTING REGULATION (EU) 2022/214 of 17 February 2022 |
L 37 |
16 |
18.2.2022 |
|
COMMISSION IMPLEMENTING REGULATION (EU) 2022/1218 of 14 July 2022 |
L 188 |
65 |
15.7.2022 |
|
COMMISSION IMPLEMENTING REGULATION (EU) 2023/150 of 20 January 2023 |
L 20 |
33 |
23.1.2023 |
|
COMMISSION IMPLEMENTING REGULATIONZ (EU) 2023/1071 of 1 June 2023 |
L 143 |
105 |
2.6.2023 |
|
COMMISSION IMPLEMENTING REGULATION (EU) 2023/2057 of 26 September 2023 |
L 238 |
94 |
27.9.2023 |
|
COMMISSION IMPLEMENTING REGULATION (EU) 2023/2618 of 23 November 2023 |
L |
1 |
24.11.2023 |
|
COMMISSION IMPLEMENTING REGULATION (EU) 2024/566 of 14 February 2024 |
L |
1 |
15.2.2024 |
COMMISSION IMPLEMENTING REGULATION (EU) 2021/620
of 15 April 2021
laying down rules for the application of Regulation (EU) 2016/429 of the European Parliament and of the Council as regards the approval of the disease-free and non-vaccination status of certain Member States or zones or compartments thereof as regards certain listed diseases and the approval of eradication programmes for those listed diseases
(Text with EEA relevance)
Article 1
Subject matter and scope
This Regulation lists in the Annexes thereto:
the Member States or zones or compartments thereof with approved compulsory eradication programmes for Category B diseases and optional eradication programmes for Category C diseases.
the Member States or zones thereof with approved disease-free status and non-vaccination status;
the compartments of Member States with recognised disease-free status.
Article 2
Infection with Brucella abortus, B. melitensis and B. suis
Article 3
Infection with Mycobacterium tuberculosis complex (M. bovis, M. caprae and M. tuberculosis) (MTBC)
Article 4
Infection with rabies virus (RABV)
Article 5
Enzootic bovine leukosis (EBL)
Article 6
Infectious bovine rhinotracheitis/infectious pustular vulvovaginitis (IBR/IPV)
Article 7
Infection with Aujeszky’s disease virus(ADV)
Article 8
Bovine viral diarrhoea (BVD)
Article 9
Infection with bluetongue virus (serotypes 1-24) (infection with BTV)
Article 10
Infestation with Varroa spp.
The Member States or zones thereof with disease-free status from infestation with Varroa spp. shall be listed in Annex IX.
Article 11
Infection with Newcastle disease virus
The Member States or zones thereof with disease-free status from infection with Newcastle disease virus without vaccination shall be listed in Annex X.
Article 12
Infection with highly pathogenic avian influenza (HPAI)
Compartments of the Member States free from HPAI shall be listed in Annex XI.
Article 13
Viral haemorrhagic septicaemia (VHS)
The following shall be listed in Part I of Annex XII:
Member States where their whole territory has disease-free status from viral haemorrhagic septicaemia (VHS);
zones or compartments of Member States where more than 75 % of the territory of the Member State has disease-free status from VHS; and
zones or compartments of Member States with disease-free status from VHS, where the water catchment area supplying those zones or compartments of the Member State is shared with another Member State or a third country.
The following shall be listed in Part II of Annex XII:
Member States where their whole territory has an approved eradication programme for VHS;
zones and compartments of Member States where more than 75 % of the territory of the Member State has an approved eradication programme for VHS; and
zones and compartments of Member States with an approved eradication programme for VHS, where the water catchment area supplying those zones or compartments of the Member State is shared with another Member State or a third country.
Article 14
Infectious haematopoietic necrosis (IHN)
The following shall be listed in Part I of Annex XIII:
Member States where their whole territory has disease-free status from infectious haematopoietic necrosis (IHN);
zones or compartments of Member States where more than 75 % of the territory of the Member State has disease-free status from IHN; and
zones or compartments of Member States with disease-free status from IHN, where the water catchment area supplying those zones or compartments of the Member State is shared with another Member State or a third country.
The following shall be listed in Part II of Annex XIII:
Member States where their whole territory has an approved eradication programme for IHN;
zones and compartments of Member States where more than 75 % of the territory of the Member State has an approved eradication programme for IHN; and
zones and compartments of Member States with an approved eradication programme for IHN, where the water catchment area supplying those zones or compartments of the Member State is shared with another Member State or a third country.
Article 15
Infection with highly polymorphic region deleted infectious salmon anaemia virus (HPR-deleted ISAV)
The following shall be listed in Part I of Annex XIV:
Member States where their whole territory has disease-free status from infection with highly polymorphic region deleted infectious salmon anaemia virus (HPR-deleted ISAV);
zones or compartments of Member States where more than 75 % of the territory of the Member State has disease-free status from infection with HPR-deleted ISAV; and
zones or compartments of Member States with disease-free status from infection with HPR-deleted ISAV, where the water catchment area supplying those zones or compartments of the Member State is shared with another Member State or a third country.
The following shall be listed in Part II of Annex XIV:
Member States where their whole territory has an approved eradication programme for infection with HPR-deleted ISAV;
zones and compartments of Member States where more than 75 % of the territory of the Member State has an approved eradication programme for infection with HPR-deleted ISAV; and
zones and compartments of Member States with an approved eradication programme for infection with HPR-deleted ISAV, where the water catchment area supplying those zones or compartments of the Member State is shared with another Member State or a third country.
Article 16
Infection with Marteilia refringens
The following shall be listed in Part I of Annex XV:
Member States where their whole territory has disease-free status from infection with Marteilia refringens;
zones or compartments of Member States where more than 75 % of the territory of the Member State has disease-free status from infection with Marteilia refringens; and
zones or compartments of Member States with disease-free status from infection with Marteilia refringens, where the water catchment area supplying those zones or compartments of the Member State is shared with another Member State or a third country.
The following shall be listed in Part II of Annex XV:
Member States where their whole territory has an approved eradication programme for infection with Marteilia refringens;
zones and compartments of Member States where more than 75 % of the territory of the Member State has an approved eradication programme for infection with Marteilia refringens; and
zones and compartments of Member States with an approved eradication programme for infection with Marteilia refringens, where the water catchment area supplying those zones or compartments of the Member State is shared with another Member State or a third country.
Article 17
Infection with Bonamia exitiosa
The following shall be listed in Part I of Annex XVI:
Member States where their whole territory has disease-free status from infection with Bonamia exitiosa;
zones or compartments of Member States where more than 75 % of the territory of the Member State has disease-free status from infection with Bonamia exitiosa; and
zones or compartments of Member States with disease-free status from infection with Bonamia exitiosa, where the water catchment area supplying those zones or compartments of the Member State is shared with another Member State or a third country.
The following shall be listed in Part II of Annex XVI:
Member States where their whole territory has an approved eradication programme for infection with Bonamia exitiosa;
zones and compartments of Member States where more than 75 % of the territory of the Member State has an approved eradication programme for infection with Bonamia exitiosa; and
zones and compartments of Member States with an approved eradication programme for infection with Bonamia exitiosa, where the water catchment area supplying those zones or compartments of the Member State is shared with another Member State or a third country.
Article 18
Infection with Bonamia ostreae
The following shall be listed in Part I of Annex XVII:
Member States where their whole territory has disease-free status from infection with Bonamia ostreae;
zones or compartments of Member States where more than 75 % of the territory of the Member State has disease-free status from infection with Bonamia ostreae; and
zones or compartments of Member States with disease-free status from infection with Bonamia ostreae, where the water catchment area supplying those zones or compartments of the Member State is shared with another Member State or a third country.
The following shall be listed in Part II of Annex XVII:
Member States where their whole territory has an approved eradication programme for infection with Bonamia ostreae;
zones and compartments of Member States where more than 75 % of the territory of the Member State has an approved eradication programme for infection with Bonamia ostreae; and
zones and compartments of Member States with an approved eradication programme for infection with Bonamia ostreae, where the water catchment area supplying those zones or compartments of the Member State is shared with another Member State or a third country.
Article 19
Infection with white spot syndrome virus (WSSV)
The following shall be listed in Part I of Annex XVIII:
Member States where their whole territory has disease-free status from infection with white spot syndrome virus (WSSV);
zones or compartments of Member States where more than 75 % of the territory of the Member State has disease-free status from infection with WSSV; and
zones or compartments of Member States with disease-free status from infection with WSSV, where the water catchment area supplying those zones or compartments of the Member State is shared with another Member State or a third country.
The following shall be listed in Part II of Annex XVIII:
Member States where their whole territory has an approved eradication programme for infection with WSSV;
zones and compartments of Member States where more than 75 % of the territory of the Member State has an approved eradication programme for infection with WSSV; and
zones and compartments of Member States with an approved eradication programme for infection with WSSV, where the water catchment area supplying those zones or compartments of the Member State is shared with another Member State or a third country.
Article 20
Repeal
The following acts are repealed:
Article 21
Entry into force and application
This Regulation shall enter into force on the third day following that of its publication in the Official Journal of the European Union.
It shall apply from 21 April 2021.
This Regulation shall be binding in its entirety and directly applicable in all Member States.
ANNEX I
INFECTION WITH BRUCELLA ABORTUS, B. MELITENSIS AND B. SUIS
PART I
Disease-free status from infection with Brucella abortus, B. melitensis and B. suis
CHAPTER 1
Member States or zones thereof with disease-free status from infection with Brucella abortus, B. melitensis and B. suis in bovine animal populations
Member State (*1) |
Territory |
Belgium |
Whole territory |
Czechia |
Whole territory |
Denmark |
Whole territory |
Germany |
Whole territory |
Estonia |
Whole territory |
Ireland |
Whole territory |
Spain |
Whole territory |
France |
Whole territory |
Croatia |
Whole territory |
Italy |
Regione Abruzzo: Provincia di Pescara, Teramo Regione Basilicata: Provincia di Matera Regione Calabria: Provincia di Vibo Valentia Regione Campania: Provincia di Avellino, Benevento, Napoli Regione Emilia-Romagna Regione Friuli Venezia Giulia Regione Lazio Regione Liguria Regione Lombardia Regione Marche Regione Molise: Provincia di Campobasso Regione Piemonte Regione Puglia: Province di Bari, Barletta-Andria-Trani, Brindisi, Lecce Regione Sardegna Regione Toscana Regione Trentino – Alto Adige Regione Umbria Regione Valle d’Aosta Regione Veneto |
Cyprus |
Whole territory |
Latvia |
Whole territory |
Lithuania |
Whole territory |
Luxembourg |
Whole territory |
Malta |
Whole territory |
Netherlands |
Whole territory |
Austria |
Whole territory |
Poland |
Whole territory |
Portugal |
Distritos Aveiro, Castelo Branco, Coimbra, Faro, Guarda, Leiria, Santarem, Setubal, Viseu Região Autónoma dos Açores: Ilhas de Corvo, Faial, Flores, Graciosa, Pico, São Jorge, Santa Maria, Terceira |
Romania |
Whole territory |
Slovenia |
Whole territory |
Slovakia |
Whole territory |
Finland |
Whole territory |
Sweden |
Whole territory |
United Kingdom (Northern Ireland) |
Northern Ireland |
(*1)
In accordance with the Agreement on the withdrawal of the United Kingdom of Great Britain and Northern Ireland from the European Union and the European Atomic Energy Community, and in particular Article 5(4) of the Protocol on Ireland/Northern Ireland in conjunction with Annex 2 to that Protocol, for the purposes of this Annex references to Member States include the United Kingdom in respect of Northern Ireland. |
CHAPTER 2
Member States or zones thereof with disease-free status from infection with Brucella abortus, B. melitensis and B. suis in ovine and caprine animal populations
Member State (*1) |
Territory |
Belgium |
Whole territory |
Czechia |
Whole territory |
Denmark |
Whole territory |
Germany |
Whole territory |
Estonia |
Whole territory |
Ireland |
Whole territory |
Spain |
Whole territory |
France |
Whole territory |
Italy |
Regione Abruzzo Regione Calabria: Province di Catanzaro, Cosenza Regione Campania: Provincia di Benevento, Napoli, Salerno Regione Emilia-Romagna Regione Friuli Venezia Giulia Regione Lazio Regione Liguria Regione Lombardia Regione Marche Regione Molise Regione Piemonte Regione Puglia: Province di Bari, Barletta-Andria-Trani, Brindisi, Lecce, Taranto Regione Sardegna Regione Toscana Regione Trentino – Alto Adige Regione Umbria Regione Valle d’Aosta Regione Veneto |
Cyprus |
Whole territory |
Latvia |
Whole territory |
Lithuania |
Whole territory |
Luxembourg |
Whole territory |
Hungary |
Whole territory |
Netherlands |
Whole territory |
Austria |
Whole territory |
Poland |
Whole territory |
Portugal |
Região Autónoma dos Açores |
Romania |
Whole territory |
Slovenia |
Whole territory |
Slovakia |
Whole territory |
Finland |
Whole territory |
Sweden |
Whole territory |
United Kingdom (Northern Ireland) |
Northern Ireland |
(*1)
In accordance with the Agreement on the withdrawal of the United Kingdom of Great Britain and Northern Ireland from the European Union and the European Atomic Energy Community, and in particular Article 5(4) of the Protocol on Ireland/Northern Ireland in conjunction with Annex 2 to that Protocol, for the purposes of this Annex references to Member States include the United Kingdom in respect of Northern Ireland. |
PART II
Member States or zones thereof with an approved eradication programme for Brucella abortus, B. melitensis and B. suis
CHAPTER 1
Member States or zones thereof with an approved eradication programme for Brucella abortus, B. melitensis and B. suis in bovine animal populations
Member State |
Territory |
Bulgaria |
Whole territory |
Greece |
Whole territory |
Hungary |
Whole territory |
Italy |
Regione Abruzzo: Provincia dell’Aquila, di Chieti Regione Basilicata: Provincia di Potenza Regione Calabria: Provincia di Catanzaro, Cosenza, Crotone, Reggio Calabria Regione Campania: Provincia di Caserta, Salerno Regione Molise: Provincia di Isernia Regione Puglia: Provincia di Foggia, Taranto Regione Sicilia |
Portugal |
Distritos Beja, Braga, Braganca, Evora, Lisboa, Portalegre, Porto, Viana do Castelo, Vila Real Região Autónoma da Madeira Região Autónoma dos Açores: Ilha de São Miguel |
CHAPTER 2
Member States or zones thereof with an approved eradication programme for Brucella abortus, B. melitensis and B. suis in ovine and caprine animal populations
Member State |
Territory |
Bulgaria |
Whole territor |
Croatia |
Whole territory |
Greece |
Whole territory |
Italy |
Regione Basilicata Regione Calabria: Provincia di Crotone, Reggio Calabria, Vibo Valentia Regione Campania: Provincia di Caserta, Avellino Regione Puglia: Provincia di Foggia Regione Sicilia |
Portugal |
Região Madeira Distritos Aveiro, Beja, Braga, Braganca, Castelo Branco, Coimbra, Evora, Faro, Guarda, Leiria, Lisboa, Portalegre, Porto, Santarem, Setubal, Viana do Castelo, Vila Real, Viseu |
ANNEX II
INFECTION WITH MYCOBACTERIUM TUBERCULOSIS COMPLEX (M. BOVIS, M. CAPRAE AND M. TUBERCULOSIS) (MTBC)
PART I
Member States or zones thereof with disease-free status from infection with MTBC
Member State |
Territory |
Belgium |
Whole territory |
Czechia |
Whole territory |
Denmark |
Whole territory |
Germany |
Whole territory |
Estonia |
Whole territory |
Spain |
Comunidad Autónoma de Canarias Comunidad Autónoma de Castilla y León: Province of Burgos, León, Valladolid Comunidad Autónoma de Cataluña Comunidad Autónoma de Galicia Comunidad Autónoma de Islas Baleares Comunidad Autónoma de Murcia Comunidad Autónoma del País Vasco Comunidad Autónoma del Principado de Asturias |
France |
Whole territory |
Italy |
Regione Abruzzo Regione Basilicata: Provincia di Matera Regione Calabria: Provincia di Catanzaro Regione Campania: Provincia di Napoli Regione Emilia-Romagna Regione Friuli Venezia Giulia Regione Lazio: Provincia di Frosinone, Latina, Rieti, Viterbo Regione Liguria Regione Lombardia Regione Marche: Provincia di Ancona, Ascoli Piceno, Fermo, Pesaro-Urbino Regione Molise Regione Piemonte Regione Puglia: Provincia di Bari, Barletta-Andria-Trani, Brindisi, Lecce, Taranto Regione Sardegna: Città metropolitana di Cagliari, Provincia di Medio Campidano, Nord Est Sardegna, Nuoro, Ogliastra, Oristano, Sulcis Iglesiente Regione Toscana Regione Trentino – Alto Adige Regione Umbria Regione Valle d’Aosta Regione Veneto |
Latvia |
Whole territory |
Lithuania |
Whole territory |
Luxembourg |
Whole territory |
Hungary |
Whole territory |
Netherlands |
Whole territory |
Austria |
Whole territory |
Poland |
Whole territory |
Portugal |
Região Algarve: all distritos Região Autónoma dos Açores except Ilha de São Miguel |
Slovenia |
Whole territory |
Slovakia |
Whole territory |
Finland |
Whole territory |
Sweden |
Whole territory |
PART II
Member States or zones thereof with an approved eradication programme for infection with MTBC
Member State (*1) |
Territory |
Bulgaria |
Whole territory |
Croatia |
Whole territory |
Cyprus |
Whole territory |
Greece |
Whole territory |
Ireland |
Whole territory |
Italy |
Regione Basilicata: Provincia di Potenza Regione Calabria: Provincia di Cosenza, Crotone, Reggio Calabria, Vibo Valentia Regione Campania: Provincia d’Avellino, Caserta, Benevento, Salerno Regione Lazio: Provincia di Roma Regione Marche: Provincia di Macerata Regione Puglia: Provincia di Foggia Regione Sardegna: Città metropolitana di Sassari Regione Sicilia |
Malta |
Whole territory |
Portugal |
Região Autónoma dos Açores: Ilha de São Miguel Região Autónoma da Madeira Distritos Aveiro, Beja, Braga, Bragança, Castelo Branco, Coimbra, Evora, Guarda, Leiria, Lisboa, Portalegre, Porto, Santarem, Setubal, Viana do Castelo, Vila Real, Viseu |
Romania |
Whole territory |
Spain |
Comunidad Autónoma de Andalucía Comunidad Autónoma de Aragón Comunidad Autónoma de Cantabria Comunidad Autónoma de Castilla-La Mancha Comunidad Autónoma de Castilla y León: Province of Ávila, Palencia, Salamanca, Segovia, Soria, Zamora Comunidad Autónoma de Extremadura Comunidad Autónoma de La Rioja Comunidad Autónoma de Madrid Comunidad Autónoma de Navarra Comunidad Autónoma de Valencia |
United Kingdom (Northern Ireland) |
Northern Ireland |
(*1)
In accordance with the Agreement on the withdrawal of the United Kingdom of Great Britain and Northern Ireland from the European Union and the European Atomic Energy Community, and in particular Article 5(4) of the Protocol on Ireland/Northern Ireland in conjunction with Annex 2 to that Protocol, for the purposes of this Annex references to Member States include the United Kingdom in respect of Northern Ireland. |
ANNEX III
INFECTION WITH THE RABIES VIRUS (RABV)
PART I
Member States or zones thereof with disease-free status from infection with RABV
Member State (*1) |
Territory |
Belgium |
Whole territory |
Bulgaria |
Whole territory |
Czechia |
Whole territory |
Denmark |
Whole territory |
Germany |
Whole territory |
Estonia |
Whole territory |
Ireland |
Whole territory |
Greece |
Whole territory |
Spain |
Whole territory |
France |
Whole territory |
Croatia |
Whole territory |
Italy |
Whole territory |
Cyprus |
Whole territory |
Latvia |
Whole territory |
Lithuania |
Whole territory |
Luxembourg |
Whole territory |
Hungary |
Whole territory except Szabolcs-Szatmár-Bereg megye |
Malta |
Whole territory |
Netherlands |
Whole territory |
Austria |
Whole territory |
Poland |
Voivodship Dolnośląskie: all powiaty Voivodship Kujawsko-pomorskie: all powiaty Voivodship Lubelskie the following powiaty: m. Lublin, Łęczyński, Parczewski, Radzyński, Świdnicki Voivodship Lubuskie: all powiaty Voivodship Łódzkie the following powiaty: Bełchatowski, Brzeziński, Kutnowski, Łaski, Łęczycki, Łowicki, Łódzki Wschodni, m. Łódź, Pabianicki, Pajęczański, Piotrkowski, m. Piotrków Trybunalski, Poddębicki, Radomszczański, Rawski, Sieradzki, Skierniewicki, m. Skierniewice, Tomaszowski, Wieluński, Wieruszowski, Zduńskowolski, Zgierski Voivodship Małopolskie: all powiaty Voivodship Mazowieckie the following powiaty: Ciechanowski, Gostyniński, Makowski, Mławski, Ostrołęcki, m. Ostrołęka, Płocki, m. Płock, Przasnyski, Sierpecki, Żuromiński Voivodship Opolskie: all powiaty Voivodship Podlaskie: all powiaty Voivodship Pomorskie: all powiaty Voivodship Śląskie: all powiaty Voivodship Świętokrzyskie the following powiaty: Buski, Kazimierski, Pińczowski, Włoszczowski Voivodship Warmińsko-mazurskie: all powiaty Voivodship Wielkopolskie: all powiaty Voivodship Zachodniopomorskie: all powiaty |
Portugal |
Whole territory |
Slovenia |
Whole territory |
Slovakia |
Whole territory, except the following regions: Humenné, Medzilaborce, Snina, Stropkov, Svidnik, Vranov nad Topl’ou in kraj Prešovský Michalovce, Sobrance, Trebišov in kraj Košický |
Finland |
Whole territory |
Sweden |
Whole territory |
United Kingdom (Northern Ireland) |
Northern Ireland |
(*1)
In accordance with the Agreement on the withdrawal of the United Kingdom of Great Britain and Northern Ireland from the European Union and the European Atomic Energy Community, and in particular Article 5(4) of the Protocol on Ireland/Northern Ireland in conjunction with Annex 2 to that Protocol, for the purposes of this Annex references to Member States include the United Kingdom in respect of Northern Ireland. |
PART II
Member States or zones thereof with an approved eradication programme for infection with RABV
Member State |
Territory |
Hungary |
Szabolcs-Szatmár-Bereg megye |
Poland |
Voivodship Lubelskie the following powiaty: Bialski, m. Biała Podlaska, Biłgorajski, Chełmski, m. Chełm, Hrubieszowski, Janowski, Krasnostawski, Kraśnicki, Lubartowski, Lubelski, Łukowski, Opolski, Puławski, Rycki, Tomaszowski, Włodawski, Zamojski, m. Zamość Voivodship Łódzkie the following powiaty: Opoczyński Voivodship Mazowieckie the following powiaty: Białobrzeski, Garwoliński, Grodziski, Grójecki, Kozienicki, Legionowski, Lipski, Łosicki, Miński, Nowodworski, Ostrowski, Otwocki, Piaseczyński, Płoński, Pruszkowski, Przysuski, Pułtuski, Radomski, m. Radom, Siedlecki, m. Siedlce, Sochaczewski, Sokołowski, Szydłowiecki, m.st. Warszawa, Warszawski Zachodni, Węgrowski, Wołomiński, Wyszkowski, Zwoleński, Żyrardowski Voivodship Podkarpackie Voivodship Świętokrzyskie the following powiaty: Jędrzejowski, Kielecki, m. Kielce, Konecki, Opatowski, Ostrowiecki, Sandomierski, Skarżyski, Starachowicki, Staszowski |
Romania |
Whole territory |
Slovakia |
Region Humenné, Medzilaborce, Snina, Stropkov, Svidnik, Vranov nad Topl’ou in kraj Prešovský Region Michalovce, Sobrance, Trebišov in kraj Košický |
ANNEX IV
ENZOOTIC BOVINE LEUKOSIS (EBL)
PART I
Member States or zones thereof with disease-free status from EBL
Member State (*1) |
Territory |
Belgium |
Whole territory |
Czechia |
Whole territory |
Denmark |
Whole territory |
Germany |
Whole territory |
Estonia |
Whole territory |
Ireland |
Whole territory |
Spain |
Whole territory |
France |
Région Auvergne et Rhône-Alpes Région Bourgogne-Franche-Comté Région Bretagne Région Centre-Val de Loire Région Corse Région Grande Est Région Hauts-de-France Région Ile-de-France Région Normandie Région Nouvelle-Aquitaine Région Occitanie Région Pays de la Loire Région Provence-Alpes-Côte d’Azur Région Guadeloupe Région Guyane Région Martinique Région Mayotte |
Italy |
Whole territory |
Cyprus |
Whole territory |
Latvia |
Whole territory |
Lithuania |
Whole territory |
Luxembourg |
Whole territory |
Netherlands |
Whole territory |
Austria |
Whole territory |
Poland |
Whole territory |
Portugal |
Whole territory, except Região Autónoma da Madeira |
Slovenia |
Whole territory |
Slovakia |
Whole territory |
Finland |
Whole territory |
Sweden |
Whole territory |
United Kingdom (Northern Ireland) |
Northern Ireland |
(*1)
In accordance with the Agreement on the withdrawal of the United Kingdom of Great Britain and Northern Ireland from the European Union and the European Atomic Energy Community, and in particular Article 5(4) of the Protocol on Ireland/Northern Ireland in conjunction with Annex 2 to that Protocol, for the purposes of this Annex references to Member States include the United Kingdom in respect of Northern Ireland. |
PART II
Member States or zones thereof with an approved eradication programme for EBL
Member State |
Territory |
Date of initial approval as referred to in Article 15(2) of Delegated Regulation (EU) 2020/689 |
Croatia |
Whole territory |
18 July 2022 |
ANNEX V
INFECTIOUS BOVINE RHINOTRACHEITIS/INFECTIOUS PUSTULAR VULVOVAGINITIS (IBR/IPV)
PART I
Member States or zones thereof with disease-free status from IBR/IPV
Member State |
Territory |
Czechia |
Whole territory |
Denmark |
Whole territory |
Germany |
Whole territory |
Italy |
Regione Valle d’Aosta Regione Trentino – Alto Adige: Provincia Autonoma di Bolzano – Alto Adige |
Austria |
Whole territory |
Finland |
Whole territory |
Sweden |
Whole territory |
PART II
Member States or zones thereof with an approved eradication programme for IBR/IPV
Member State |
Territory |
Date of initial approval as referred to in point 2 of Article 15 of Delegated Regulation (EU) 2020/689 |
Belgium |
Whole territory |
21 April 2021 |
France |
Région Auvergne et Rhône-Alpes Région Bourgogne-Franche-Comté Région Bretagne Région Centre-Val de Loire Région Grande Est Région Hauts-de-France Région Ile-de-France Région Normandie Région Nouvelle-Aquitaine Région Occitanie Région Pays de la Loire Région Provence-Alpes-Côte d’Azur |
21 April 2021 |
Italy |
Region Friuli Venezia Giulia Regione Trentino – Alto Adige: Provincia Autonoma di Trento |
21 April 2021 |
Luxembourg |
Whole territory |
21 April 2021 |
Slovakia |
Kraj Bratislava Kraj Košice Kraj Prešov Kraj Trnava Kraj Žilina |
5 June 2023 |
ANNEX VI
AUJESZKY’S DISEASE VIRUS (ADV)
PART I
Member States or zones thereof with disease-free status from infection with ADV
Member State (*1) |
Territory |
Belgium |
Whole territory |
Czechia |
Whole territory |
Denmark |
Whole territory |
Germany |
Whole territory |
Estonia |
Whole territory |
Ireland |
Whole territory |
France |
The departments of Ain, Aisne, Allier, Alpes-de-Haute-Provence, Alpes-Maritimes, Ardèche, Ardennes, Ariège, Aube, Aude, Aveyron, Bas-Rhin, Bouches-du-Rhône, Calvados, Cantal, Charente, Charente-Maritime, Cher, Corrèze, Côte-d’Or, Côtes-d’Armor, Creuse, Deux-Sèvres, Dordogne, Doubs, Drôme, Essonne, Eure, Eure-et-Loir, Finistère, Gard, Gers, Gironde, Hautes-Alpes, Hauts-de-Seine, Haute Garonne, Haute-Loire, Haute-Marne, Hautes-Pyrénées, Haut-Rhin, Haute-Saône, Haute-Savoie, Haute-Vienne, Hérault, Indre, Ille-et-Vilaine, Indre-et-Loire, Isère, Jura, Landes, Loire, Loire-Atlantique, Loir-et-Cher, Loiret, Lot, Lot-et-Garonne, Lozère, Maine-et-Loire, Manche, Marne, Mayenne, Meurthe-et-Moselle, Meuse, Morbihan, Moselle, Nièvre, Nord, Oise, Orne, Paris, Pas-de-Calais, Pyrénées-Atlantiques, Pyrénées-Orientales, Puy-de-Dôme, Réunion, Rhône, Sarthe, Saône-et-Loire, Savoie, Seine-et-Marne, Seine-Maritime, Seine-Saint-Denis, Somme, Tarn, Tarn-et-Garonne, Territoire de Belfort, Val-de-Marne, Val-d’Oise, Var, Vaucluse, Vendée, Vienne, Vosges, Yonne, Yvelines |
Italy |
Regione Friuli Venezia Giulia Regione Trentino – Alto Adige Regione Veneto |
Cyprus |
Whole territory |
Luxembourg |
Whole territory |
Hungary |
Whole territory |
Netherlands |
Whole territory |
Austria |
Whole territory |
Poland |
Whole territory |
Portugal |
Região Autónoma dos Açores |
Slovenia |
Whole territory |
Slovakia |
Whole territory |
Finland |
Whole territory |
Sweden |
Whole territory |
United Kingdom (Northern Ireland) |
Northern Ireland |
(*1)
In accordance with the Agreement on the withdrawal of the United Kingdom of Great Britain and Northern Ireland from the European Union and the European Atomic Energy Community, and in particular Article 5(4) of the Protocol on Ireland/Northern Ireland in conjunction with Annex 2 to that Protocol, for the purposes of this Annex references to Member States include the United Kingdom in respect of Northern Ireland. |
PART II
Member States or zones thereof with an approved eradication programme for infection with ADV
Member State |
Territory |
Date of initial approval as referred to in point 2 of Article 15 of Delegated Regulation (EU) 2020/689 |
Spain |
Whole territory |
21 April 2021 |
Italy |
Regione Abruzzo Regione Apulia Regione Basilicata Regione Calabria Regione Campania Regione Emilia-Romagna Regione Lazio Regione Liguria Regione Lombardia Regione Marche Regione Molise Regione Piemonte Regione Sicilia Regione Toscana Regione Valle d’Aosta Regione Umbria |
21 April 2021 |
Lithuania |
Whole territory |
21 April 2021 |
▼M6 ————— |
||
Portugal |
Whole peninsular territory |
21 April 2021 |
ANNEX VII
BOVINE VIRAL DIARRHOEA (BVD)
PART I
Member States or zones thereof with disease-free status from BVD
Member State |
Territory |
Austria |
Whole territory |
Denmark |
Whole territory |
Finland |
Whole territory |
Germany |
Bundesland Baden-Württemberg Bundesland Bayern Bundesland Brandenburg Bundesland Bremen Bundesland Hamburg Bundesland Hessen Bundesland Mecklenburg-Vorpommern Bundesland Niedersachsen, except Landkreis Cuxhaven, Göttingen, Northeim, Oldenburg, Stade Bundesland Nordrhein-Westfalen, except Kreis Borken, Gütersloh, Höxter, Kleve, Paderborn Bundesland Schleswig-Holstein, except Kreis Rendsburg-Eckernförde Bundesland Rheinland-Pfalz Bundesland Saarland Bundesland Sachsen Bundesland Sachsen-Anhalt Bundesland Thüringen |
Sweden |
Whole territory |
PART II
Member States or zones thereof with an approved eradication programme for BVD
Member State |
Territory |
Date of initial approval as referred to in Article 15(2) of Delegated Regulation (EU) 2020/689 |
Germany |
Bundesland Berlin Bundesland Niedersachsen: Landkreis Cuxhaven, Göttingen, Northeim, Oldenburg, Stade Bundesland Nordrhein-Westfalen: Kreis Borken, Gütersloh, Höxter, Kleve, Paderborn Bundesland Schleswig-Holstein: Kreis Rendsburg-Eckernförde |
21 February 2022 |
Ireland |
Whole territory |
18 July 2022 |
ANNEX VIII
INFECTION WITH BLUETONGUE VIRUS (BTV)
PART I
Member States or zones thereof with disease-free status from infection with BTV
Member State (*1) |
Territory |
▼M8 ————— |
|
Czechia |
Whole territory |
Denmark |
Whole territory |
Germany |
Whole territory except Bundesland Bremen, Niedersachsen, Nordrhein-Westfalen |
Estonia |
Whole territory |
Ireland |
Whole territory |
Spain |
Comunidad Autónoma de Aragón Comunidad Autónoma de Canarias Comunidad Autónoma de Castilla-La Mancha: Province of Guadalajara Comunidad Autónoma de Castilla y León, except the following areas: Province of Ávila Province of Salamanca Cantalejo, Carbonero El Mayor, Santa María la Real de Nieva, Segovia, Villacastín in the Province of Segovia Alcañices, Bermillo de Sayago, Puebla de Sanabria in the Province of Zamora Comunidad Autónoma de Cataluña Comunidad Autónoma de La Rioja Comunidad Autónoma de las Islas Baleares Comunidad Autónoma de Navarra Comunidad Autónoma del País Vasco Comunidad Autónoma de Valencia |
Italy |
Provincia Autonoma di Bolzano – Alto Adige Regione Valle d’Aosta Regione Friuli Venezia Giulia |
Latvia |
Whole territory |
Lithuania |
Whole territory |
Luxembourg |
Whole territory |
Hungary |
Whole territory |
▼M8 ————— |
|
Austria |
Whole territory |
Poland |
Whole territory |
Portugal |
Região Autónoma dos Açores Região Autónoma da Madeira |
Slovenia |
Whole territory |
Slovakia |
Whole territory |
Finland |
Whole territory |
Sweden |
Whole territory |
United Kingdom (Northern Ireland) |
Northern Ireland |
(*1)
In accordance with the Agreement on the withdrawal of the United Kingdom of Great Britain and Northern Ireland from the European Union and the European Atomic Energy Community, and in particular Article 5(4) of the Protocol on Ireland/Northern Ireland in conjunction with Annex 2 to that Protocol, for the purposes of this Annex references to Member States include the United Kingdom in respect of Northern Ireland. |
PART II
Member States or zones thereof with an approved eradication programme for infection with BTV
Member State |
Territory |
Date of initial approval as referred to in Article 15(2) of Delegated Regulation (EU) 2020/689 |
Spain |
Comunidad Autónoma de Andalucía Comunidad Autónoma de Castilla-La Mancha, except the Province of Guadalajara Comunidad Autónoma de Asturias Comunidad Autónoma de Cantabria Comunidad Autónoma de Castilla y León: Province of Ávila Province of Salamanca Province of Segovia, the following districts: Cantalejo, Carbonero El Mayor, Santa María la Real de Nieva, Segovia, Villacastín Province of Zamora, the following districts: Alcañices, Bermillo de Sayago, Puebla de Sanabria Comunidad Autónoma de Extremadura Comunidad Autónoma de Galicia Comunidad Autónoma de Madrid Comunidad Autónoma de Murcia |
21 February 2022 |
ANNEX IX
INFESTATION WITH VARROA SPP.
Member States or zones thereof with disease-free status from infestation with Varroa spp.
ANNEX X
INFECTION WITH NEWCASTLE DISEASE VIRUS
Member States or zones thereof with disease-free status from infection with Newcastle disease virus without vaccination
Member State |
Territory |
Finland |
Whole territory |
Sweden |
Whole territory |
ANNEX XI
HIGHLY PATHOGENIC AVIAN INFLUENZA (HPAI)
Compartments free from HPAI
Member State |
Name |
France |
Compartiment ISA Bretagne comprising the establishments with codes EDE 22080055, 22277180, 22203429, 22059174 and 22295000. Compartiment SASSO Sabres comprising the establishment with Code EDE 40246082. Compartiment SASSO Soulitré comprising the establishment with Code EDE 72341105. |
Netherlands |
Verbeek’s poultry international B.V with approval number 1122. Institut de selection animale B.V with approval number 2338. Cobb Europe B.V. with approval number 2951. |
ANNEX XII
VIRAL HAEMORRHAGIC SEPTICAEMIA (VHS)
PART I
Member States whose whole territory has disease-free status from VHS;
zones or compartments of Member States where more than 75 % of the territory of the Member State has disease-free status from VHS; and
zones or compartments of Member States with disease-free status from VHS, where the water catchment area supplying those zones or compartments of the Member State is shared with another Member State or a third country
Member State (*1) |
Territory |
Denmark |
Whole continental territory |
Ireland |
Whole territory |
Cyprus |
Whole continental territory |
Finland |
Whole territory |
Sweden |
Whole territory |
United Kingdom (Northern Ireland) |
Northern Ireland |
(*1)
In accordance with the Agreement on the withdrawal of the United Kingdom of Great Britain and Northern Ireland from the European Union and the European Atomic Energy Community, and in particular Article 5(4) of the Protocol on Ireland/Northern Ireland in conjunction with Annex 2 to that Protocol, for the purposes of this Annex references to Member States include the United Kingdom in respect of Northern Ireland. |
PART II
Member States where their whole territory has an approved eradication programme for VHS;
zones and compartments of Member States where more than 75 % of the territory of the Member State has an approved eradication programme for VHS;
and zones and compartments of Member States with an approved eradication programme for VHS, where the water catchment area supplying those zones or compartments of the Member State is shared with another Member State or a third country
Member State |
Territory |
Date of initial approval as referred to in point 2 of Article 49 of Delegated Regulation (EU) 2020/689 |
Estonia |
Whole territory |
21 April 2021 |
ANNEX XIII
INFECTIOUS HAEMATOPOIETIC NECROSIS (IHN)
PART I
Member States where their whole territory has disease-free status from IHN;
zones or compartments of Member States where more than 75 % of the territory of the Member State has disease-free status from IHN;
and zones or compartments of Member States with disease-free status from IHN, where the water catchment area supplying those zones or compartments of the Member State is shared with another Member State or a third country
Member State (*1) |
Territory |
▼M3 ————— |
|
Ireland |
Whole territory |
Cyprus |
Whole continental territory |
Finland |
Whole territory, except for the following: 1) the coastal compartment comprised of the parts of Föglö, Lumparland, Lemland, Vårdö municipalities that are contained within a circle of radius 19,331 km, centered on WGS84 coordinates Lat 59.975253701°, Lon 20.454027317° 2) the coastal compartment comprised of the parts of Eckerö and Hammarland municipalities that are contained within a circle of radius 10 km, centered on WGS84 coordinates Lat 60.207175390°, Lon 19.507907780° |
Sweden |
Whole territory |
United Kingdom (Northern Ireland) |
Northern Ireland |
(*1)
In accordance with the Agreement on the withdrawal of the United Kingdom of Great Britain and Northern Ireland from the European Union and the European Atomic Energy Community, and in particular Article 5(4) of the Protocol on Ireland/Northern Ireland in conjunction with Annex 2 to that Protocol, for the purposes of this Annex references to Member States include the United Kingdom in respect of Northern Ireland. |
PART II
Member States where their whole territory has an approved eradication programme for IHN;
zones and compartments of Member States where more than 75 % of the territory of the Member State has an approved eradication programme for IHN; and
zones and compartments of Member States with an approved eradication programme for IHN, where the water catchment area supplying those zones or compartments of the Member State is shared with another Member State or a third country
Member State |
Territory |
Date of initial approval as referred to in point 2 of Article 49 of Delegated Regulation (EU) 2020/689 |
Estonia |
Whole territory |
21 April 2021 |
ANNEX XIV
INFECTION WITH HIGHLY POLYMORPHIC REGION DELETED INFECTIOUS SALMON ANAEMIA VIRUS (HPR-DELETED ISAV)
PART I
Member States where their whole territory has disease-free status from infection with HPR-deleted ISAV;
zones or compartments of Member States where more than 75 % of the territory of the Member State has disease-free status from infection with HPR-deleted ISAV; and
zones or compartments of Member States with disease-free status from infection with HPR-deleted ISAV, where the water catchment area supplying those zones or compartments of the Member State is shared with another Member State or a third country
Member State (*1) |
Territory |
Belgium |
Whole territory |
Bulgaria |
Whole territory |
Czechia |
Whole territory |
Denmark |
Whole territory |
Germany |
Whole territory |
Estonia |
Whole territory |
Ireland |
Whole territory |
Greece |
Whole territory |
Spain |
Whole territory |
France |
Whole territory |
Croatia |
Whole territory |
Italy |
Whole territory |
Cyprus |
Whole territory |
Latvia |
Whole territory |
Lithuania |
Whole territory |
Luxembourg |
Whole territory |
Hungary |
Whole territory |
Malta |
Whole territory |
Netherlands |
Whole territory |
Austria |
Whole territory |
Poland |
Whole territory |
Portugal |
Whole territory |
Romania |
Whole territory |
Slovenia |
Whole territory |
Slovakia |
Whole territory |
Finland |
Whole territory |
Sweden |
Whole territory |
United Kingdom (Northern Ireland) |
Northern Ireland |
(*1)
In accordance with the Agreement on the withdrawal of the United Kingdom of Great Britain and Northern Ireland from the European Union and the European Atomic Energy Community, and in particular Article 5(4) of the Protocol on Ireland/Northern Ireland in conjunction with Annex 2 to that Protocol, for the purposes of this Annex references to Member States include the United Kingdom in respect of Northern Ireland. |
PART II
Member States where their whole territory has an approved eradication programme for infection with HPR-deleted ISAV;
zones and compartments of Member States where more than 75 % of the territory of the Member State has an approved eradication programme for infection with HPR-deleted ISAV; and
zones and compartments of Member States with an approved eradication programme for infection with HPR-deleted ISAV, where the water catchment area supplying those zones or compartments of the Member State is shared with another Member State or a third country
None at present.
ANNEX XV
INFECTION WITH MARTEILIA REFRINGENS
PART I
Member States where their whole territory has disease-free status from infection with Marteilia refringens;
zones or compartments of Member States where more than 75 % of the territory of the Member State has disease-free status from infection with Marteilia refringens; and
zones or compartments of Member States with disease-free status from infection with Marteilia refringens, where the water catchment area supplying those zones or compartments of the Member State is shared with another Member State or a third country
Member State (*1) |
Territory |
Ireland |
Whole territory |
United Kingdom (Northern Ireland) |
The whole coastline of Northern Ireland, except for Belfast Lough and Dundrum Bay. |
(*1)
In accordance with the Agreement on the withdrawal of the United Kingdom of Great Britain and Northern Ireland from the European Union and the European Atomic Energy Community, and in particular Article 5(4) of the Protocol on Ireland/Northern Ireland in conjunction with Annex 2 to that Protocol, for the purposes of this Annex references to Member States include the United Kingdom in respect of Northern Ireland. |
PART II
Member States where their whole territory has an approved eradication programme for infection with Marteilia refringens;
zones and compartments of Member States where more than 75 % of the territory of the Member State has an approved eradication programme for infection with Marteilia refringens; and
zones and compartments of Member States with an approved eradication programme for infection with Marteilia refringens, where the water catchment area supplying those zones or compartments of the Member State is shared with another Member State or a third country
None at present.
ANNEX XVI
INFECTION WITH BONAMIA EXITIOSA
PART I
Member States where their whole territory has disease-free status from infection with Bonamia exitiosa;
zones or compartments of Member States where more than 75 % of the territory of the Member State has disease-free status from infection with Bonamia exitiosa; and
zones or compartments of Member States with disease-free status from infection with Bonamia exitiosa, where the water catchment area supplying those zones or compartments of the Member State is shared with another Member State or a third country
Member State |
Territory |
Estonia |
Whole territory |
PART II
Member States where their whole territory has an approved eradication programme for infection with Bonamia exitiosa;
zones and compartments of Member States where more than 75 % of the territory of the Member State has an approved eradication programme for infection with Bonamia exitiosa; and
zones and compartments of Member States with an approved eradication programme for infection with Bonamia exitiosa, where the water catchment area supplying those zones or compartments of the Member State is shared with another Member State or a third country
None at present.
ANNEX XVII
INFECTION WITH BONAMIA OSTREAE
PART I
Member States where their whole territory has disease-free status from infection with Bonamia ostreae;
zones or compartments of Member States where more than 75 % of the territory of the Member State has disease-free status from infection with Bonamia ostreae; and
zones or compartments of Member States with disease-free status from infection with Bonamia ostreae, where the water catchment area supplying those zones or compartments of the Member State is shared with another Member State or a third country
Member State (*1) |
Territory |
Estonia |
Whole territory |
Ireland |
The whole coastline of Ireland, except: Cork Harbour; Galway Bay; Ballinakill Harbour; Clew Bay; Achill Sound; Loughmore, Blacksod Bay; Lough Foyle; Lough Swilly; and Kilkieran Bay. |
United Kingdom (Northern Ireland) |
The whole coastline of Northern Ireland, except: Lough Foyle and Strangford Lough. |
(*1)
In accordance with the Agreement on the withdrawal of the United Kingdom of Great Britain and Northern Ireland from the European Union and the European Atomic Energy Community, and in particular Article 5(4) of the Protocol on Ireland/Northern Ireland in conjunction with Annex 2 to that Protocol, for the purposes of this Annex references to Member States include the United Kingdom in respect of Northern Ireland. |
PART II
Member States where their whole territory has an approved eradication programme for infection with Bonamia ostreae;
zones and compartments of Member States where more than 75 % of the territory of the Member State has an approved eradication programme for infection with Bonamia ostreae; and
zones and compartments of Member States with an approved eradication programme for infection with Bonamia ostreae, where the water catchment area supplying those zones or compartments of the Member State is shared with another Member State or a third country
None at present.
ANNEX XVIII
INFECTION WITH WHITE SPOT SYNDROME VIRUS (WSSV)
PART I
Member States where their whole territory has disease-free status from infection with WSSV;
zones or compartments of Member States where more than 75 % of the territory of the Member State has disease-free status from infection with WSSV; and
zones or compartments of Member States with disease-free status from infection with WSSV, where the water catchment area supplying those zones or compartments of the Member State is shared with another Member State or a third country
None at present.
PART II
Member States where their whole territory has an approved eradication programme for infection with WSSV;
zones and compartments of Member States where more than 75 % of the territory of the Member State has an approved eradication programme for infection with WSSV; and
zones and compartments of Member States with an approved eradication programme for infection with WSSV, where the water catchment area supplying those zones or compartments of the Member State is shared with another Member State or a third country
None at present.
( 1 ) In accordance with the Agreement on the withdrawal of the United Kingdom of Great Britain and Northern Ireland from the European Union and the European Atomic Energy Community, and in particular Article 5(4) of the Protocol on Ireland/Northern Ireland in conjunction with Annex 2 to that Protocol, for the purposes of this Regulation references to Member States include the United Kingdom in respect of Northern Ireland.